Dangerous Prescribing and Healthcare Fragmentation: Evidence from Opioids
Author
Abstract
Suggested Citation
Note: AG EH
Download full text from publisher
Other versions of this item:
- Ericson, Keith Marzilli & Sacarny, Adam & Zhou, Annetta, 2023. "Dangerous prescribing and healthcare fragmentation: Evidence from opioids," Journal of Public Economics, Elsevier, vol. 225(C).
References listed on IDEAS
- Randall D. Cebul & James B. Rebitzer & Lowell J. Taylor & Mark E. Votruba, 2008.
"Organizational Fragmentation and Care Quality in the U.S. Healthcare System,"
Journal of Economic Perspectives, American Economic Association, vol. 22(4), pages 93-113, Fall.
- Randall D. Cebul & James B. Rebitzer & Lowell J. Taylor & Mark Votruba, 2008. "Organizational Fragmentation and Care Quality in the U.S. Health Care System," NBER Working Papers 14212, National Bureau of Economic Research, Inc.
- Agha, Leila & Frandsen, Brigham & Rebitzer, James B., 2019.
"Fragmented division of labor and healthcare costs: Evidence from moves across regions,"
Journal of Public Economics, Elsevier, vol. 169(C), pages 144-159.
- Leila Agha & Brigham Frandsen & James B. Rebitzer, 2017. "Fragmented Division of Labor and Healthcare Costs: Evidence from Moves Across Regions," NBER Working Papers 23078, National Bureau of Economic Research, Inc.
- Thomas C. Buchmueller & Colleen Carey, 2018.
"The Effect of Prescription Drug Monitoring Programs on Opioid Utilization in Medicare,"
American Economic Journal: Economic Policy, American Economic Association, vol. 10(1), pages 77-112, February.
- Thomas C. Buchmueller & Colleen Carey, 2017. "The Effect of Prescription Drug Monitoring Programs on Opioid Utilization in Medicare," NBER Working Papers 23148, National Bureau of Economic Research, Inc.
- Laurence C. Baker & M. Kate Bundorf & Daniel P. Kessler, 2020. "Does Multispecialty Practice Enhance Physician Market Power?," American Journal of Health Economics, University of Chicago Press, vol. 6(3), pages 324-347.
- Anca M. Grecu & Dhaval M. Dave & Henry Saffer, 2019.
"Mandatory Access Prescription Drug Monitoring Programs and Prescription Drug Abuse,"
Journal of Policy Analysis and Management, John Wiley & Sons, Ltd., vol. 38(1), pages 181-209, January.
- Dhaval M. Dave & Anca M. Grecu & Henry Saffer, 2017. "Mandatory Access Prescription Drug Monitoring Programs and Prescription Drug Abuse," NBER Working Papers 23537, National Bureau of Economic Research, Inc.
- Amy Finkelstein & Matthew Gentzkow & Heidi Williams, 2016.
"Sources of Geographic Variation in Health Care: Evidence From PatientMigration,"
The Quarterly Journal of Economics, President and Fellows of Harvard College, vol. 131(4), pages 1681-1726.
- Amy Finkelstein & Matthew Gentzkow & Heidi Williams, 2014. "Sources of Geographic Variation in Health Care: Evidence from Patient Migration," NBER Working Papers 20789, National Bureau of Economic Research, Inc.
- Leila Agha & Keith Marzilli Ericson & Xiaoxi Zhao, 2023. "The Impact of Organizational Boundaries on Health Care Coordination and Utilization," American Economic Journal: Economic Policy, American Economic Association, vol. 15(3), pages 184-214, August.
- Jill Horwitz & Corey S. Davis & Lynn S. McClelland & Rebecca S. Fordon & Ellen Meara, 2018. "The Problem of Data Quality in Analyses of Opioid Regulation: The Case of Prescription Drug Monitoring Programs," NBER Working Papers 24947, National Bureau of Economic Research, Inc.
- Capps, Cory & Dranove, David & Ody, Christopher, 2018. "The effect of hospital acquisitions of physician practices on prices and spending," Journal of Health Economics, Elsevier, vol. 59(C), pages 139-152.
Most related items
These are the items that most often cite the same works as this one and are cited by the same works as this one.- Leila Agha & Keith Marzilli Ericson & Xiaoxi Zhao, 2020. "The Impact of Organizational Boundaries on Healthcare Coordination and Utilization," NBER Working Papers 28179, National Bureau of Economic Research, Inc.
- Brekke, Kurt R. & Siciliani, Luigi & Straume, Odd Rune, 2024.
"Competition, quality and integrated health care,"
Journal of Health Economics, Elsevier, vol. 95(C).
- Kurt R. Brekke & Luigi Siciliani & Odd Rune Straume, 2021. "Competition, quality and integrated health care," NIPE Working Papers 11/2021, NIPE - Universidade do Minho.
- Gihleb, Rania & Giuntella, Osea & Zhang, Ning, 2020.
"Prescription drug monitoring programs and neonatal outcomes,"
Regional Science and Urban Economics, Elsevier, vol. 81(C).
- Gihleb, Rania & Giuntella, Osea & Zhang, Ning, 2019. "Prescription Drug Monitoring Programs and Neonatal Outcomes," IZA Discussion Papers 12796, Institute of Labor Economics (IZA).
- Simone Balestra & Helge Liebert & Nicole Maestas & Tisamarie B. Sherry, 2021.
"Behavioral Responses to Supply-Side Drug Policy During the Opioid Epidemic,"
NBER Working Papers
29596, National Bureau of Economic Research, Inc.
- Balestra, Simone & Liebert, Helge & Maestas, Nicole & Sherry, Tisamarie B., 2022. "Behavioral Responses to Supply-Side Drug Policy During the Opioid Epidemic," IZA Discussion Papers 15221, Institute of Labor Economics (IZA).
- Simone Balestra & Helge Liebert & Nicole Maestas & Tisamarie B. Sherry, 2022. "Behavioral Responses to Supply-Side Drug Policy During the Opioid Epidemic," CESifo Working Paper Series 9704, CESifo.
- Tamara Bischof & Boris Kaiser, 2021.
"Who cares when you close down? The effects of primary care practice closures on patients,"
Health Economics, John Wiley & Sons, Ltd., vol. 30(9), pages 2004-2025, September.
- Tamara Bischof & Boris Kaiser, 2019. "Who Cares When You Close Down? The Effects of Primary Care Practice Closures on Patients," Diskussionsschriften dp1907, Universitaet Bern, Departement Volkswirtschaft.
- Gal Wettstein, 2019. "Health insurance and opioid deaths: Evidence from the Affordable Care Act young adult provision," Health Economics, John Wiley & Sons, Ltd., vol. 28(5), pages 666-677, May.
- Liebman, Eli & Lawler, Emily C. & Dunn, Abe & Ridley, David B., 2023.
"Consequences of a shortage and rationing: Evidence from a pediatric vaccine,"
Journal of Health Economics, Elsevier, vol. 92(C).
- Eli B. Liebman & Emily C. Lawler & Abe Dunn & David B. Ridley, 2023. "Consequences of a Shortage and Rationing: Evidence from a Pediatric Vaccine," NBER Working Papers 31479, National Bureau of Economic Research, Inc.
- David Cho & Alvaro Mezza & Joshua Montes, 2022. "Choices and Implications when Measuring the Local Supply of Prescription Opioids," Finance and Economics Discussion Series 2022-078, Board of Governors of the Federal Reserve System (U.S.).
- Dhaval Dave & Monica Deza & Brady Horn, 2021.
"Prescription drug monitoring programs, opioid abuse, and crime,"
Southern Economic Journal, John Wiley & Sons, vol. 87(3), pages 808-848, January.
- Dhaval Dave & Monica Deza & Brady P. Horn, 2018. "Prescription Drug Monitoring Programs, Opioid Abuse, and Crime," NBER Working Papers 24975, National Bureau of Economic Research, Inc.
- David Cho & Daniel I. García & Joshua Montes & Alison E. Weingarden, 2021. "Labor Market Effects of the Oxycodone-Heroin Epidemic," Finance and Economics Discussion Series 2021-025, Board of Governors of the Federal Reserve System (U.S.).
- Orgul Ozturk & Yuan Hong & Suzanne McDermott & Margaret Turk, 2021. "Prescription Drug Monitoring Programs and Opioid Prescriptions for Disability Conditions," Applied Health Economics and Health Policy, Springer, vol. 19(3), pages 415-428, May.
- Shishir Shakya & Collin Hodges, 2023. "Must‐access prescription drug monitoring programs and retail opioid sales," Contemporary Economic Policy, Western Economic Association International, vol. 41(1), pages 146-165, January.
- Thomas C. Buchmueller & Colleen M. Carey & Giacomo Meille, 2020. "How well do doctors know their patients? Evidence from a mandatory access prescription drug monitoring program," Health Economics, John Wiley & Sons, Ltd., vol. 29(9), pages 957-974, September.
- Lindsey Rose Bullinger & Benjamin C. Ward, 2021. "What about the children? How opioid use affects child well‐being," Contemporary Economic Policy, Western Economic Association International, vol. 39(4), pages 737-759, October.
- Deiana Claudio & Giua Ludovica, 2021. "The Intended and Unintended Effects of Opioid Policies on Prescription Opioids and Crime," The B.E. Journal of Economic Analysis & Policy, De Gruyter, vol. 21(2), pages 751-792, April.
- Lucy Xiaolu Wang, 2021. "The complementarity of drug monitoring programs and health IT for reducing opioid‐related mortality and morbidity," Health Economics, John Wiley & Sons, Ltd., vol. 30(9), pages 2026-2046, September.
- Kaestner, Robert & Ziedan, Engy, 2023. "Effects of prescription opioids on employment, earnings, marriage, disability and mortality: Evidence from state opioid control policies," Labour Economics, Elsevier, vol. 82(C).
- Kim, Bokyung, 2021. "Must-access prescription drug monitoring programs and the opioid overdose epidemic: The unintended consequences," Journal of Health Economics, Elsevier, vol. 75(C).
- Leila Agha & Keith Marzilli Ericson & Kimberley H. Geissler & James B. Rebitzer, 2022. "Team Relationships and Performance: Evidence from Healthcare Referral Networks," Management Science, INFORMS, vol. 68(5), pages 3735-3754, May.
- Christopher J. Ruhm, 2019.
"Shackling the Identification Police?,"
Southern Economic Journal, John Wiley & Sons, vol. 85(4), pages 1016-1026, April.
- Christopher J. Ruhm, 2018. "Shackling the Identification Police?," NBER Working Papers 25320, National Bureau of Economic Research, Inc.
More about this item
JEL classification:
- I11 - Health, Education, and Welfare - - Health - - - Analysis of Health Care Markets
- I12 - Health, Education, and Welfare - - Health - - - Health Behavior
- L14 - Industrial Organization - - Market Structure, Firm Strategy, and Market Performance - - - Transactional Relationships; Contracts and Reputation
- L22 - Industrial Organization - - Firm Objectives, Organization, and Behavior - - - Firm Organization and Market Structure
NEP fields
This paper has been announced in the following NEP Reports:- NEP-HEA-2022-06-13 (Health Economics)
- NEP-IND-2022-06-13 (Industrial Organization)
Statistics
Access and download statisticsCorrections
All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:nbr:nberwo:29992. See general information about how to correct material in RePEc.
If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.
If CitEc recognized a bibliographic reference but did not link an item in RePEc to it, you can help with this form .
If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.
For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: the person in charge (email available below). General contact details of provider: https://edirc.repec.org/data/nberrus.html .
Please note that corrections may take a couple of weeks to filter through the various RePEc services.